Moving into clinical trials is an important stage in the development of a combination product. It represents the transition from device development activities to clinical investigation, where the drug-device combination is evaluated within a clinical development program. We are pleased to see PiccoJect™ supporting pharmaceutical partners as their programs advance toward commercialization.

PiccoJect™ is a two-step autoinjector designed for subcutaneous drug delivery and compatibility with ISO-standard pre-filled syringes. Developed to support the needs of modern injectable therapies, the platform combines a simplified architecture with customization options and a scalable manufacturing approach. With only eight components, PiccoJect™ is designed to facilitate efficient manufacturing and supply chain management.

As pharmaceutical companies continue to develop biologics and other injectable therapies, the requirements for reliable, user-friendly drug delivery devices continue to evolve. PiccoJect™ is designed to address these needs throughout clinical development and future commercial launch planning, providing flexibility across a range of drug delivery applications.

Designed to meet the evolving needs of pharmaceutical partners, PiccoJect combines essential USPs all in one simple autoinjector with only 8 parts.

✔️ Best in class viscosity handling

✔️ Users prefer PiccoJect over current standard autoinjectors

✔️ Sustainable version as standard offering

✔️ Global manufacturing & assembly infrastructure

✔️ Customization possible

✔️ Compatible with ISO Standard pre-filled syringe

This is excellence through simplicity!